World's Best Scientists 2026 revealed!
Lars Wallentin

Lars Wallentin

Award Badge
Best Scientists
2025
Award Badge
Medicine
Sweden
2026

D-Index & Metrics

Best Scientists

D-Index
173
Citations
146312
World Ranking
760
National Ranking
12

Medicine

D-Index
174
Citations
154932
World Ranking
447
National Ranking
10

Lars Wallentin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lars Wallentin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,172 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lars Wallentin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Wallentin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 174 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Sweden Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Sweden Leader Award
  • 2023 - Research.com Medicine in Sweden Leader Award
  • 1998 - Nordic Medical Prize, SalusAnsvar/Ulf Nilsonnes Foundation for Medical Research

Overview

Lars Wallentin is affiliated with Uppsala University in Sweden and has made significant contributions in the field of medicine, particularly within cardiology and cardiovascular medicine. Their research output spans over 300 publications, with a focus on subfields including molecular biology, surgery, rheumatology, and radiology, nuclear medicine, and imaging.

The scientist's work primarily addresses topics related to cardiovascular health and disease management. Key research areas include:

  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Cardiac Arrhythmias and Treatments
  • Cardiac Imaging and Diagnostics
  • GDF15 and Related Biomarkers
  • Heart Failure Treatment and Management

Lars Wallentin has contributed to numerous publications in several high-impact medical journals. Frequent venues for their work include:

  • European Heart Journal
  • Circulation
  • Journal of the American College of Cardiology
  • Journal of the American Heart Association
  • European Heart Journal - Quality of Care and Clinical Outcomes

Some of the recent papers featuring Lars Wallentin's research are:

  • "Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation," 2020, European Heart Journal
  • "Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease," 2020, Circulation
  • "Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome," 2020, Circulation
  • "Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals," 2020, Nature Metabolism
  • "Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets," 2023, Nature Immunology

Collaboration plays an important role in their work, with frequent co-authors including:

  • Christopher B. Granger
  • Agneta Siegbahn
  • Renato D. Lópes
  • Johan Lindbäck
  • Ziad Hijazi

Recognition for Lars Wallentin's contributions includes receiving the Nordic Medical Prize awarded by SalusAnsvar and the Ulf Nilsonnes Foundation for Medical Research in 1998.

Best Publications

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

    Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman

  • Universal definition of myocardial infarction.

    Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe

  • Discovery and refinement of loci associated with lipid levels

    Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta;Gina M. Peloso;Gina M. Peloso;Gina M. Peloso

  • Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction

    J. S. Alpert;E. Antman;F. Apple;P. W. Armstrong

  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

    J.P. Bassand;C.W. Hamm;D. Ardissino;E. Boersma

  • Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

    Bertil Lindahl;Henrik Toss;Agneta Siegbahn;Per Venge

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden

    Bo Lagerqvist;Stefan K. James;Ulf Stenestrand;Johan Lindbäck

  • Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

    John W. Eikelboom;Lars Wallentin;Stuart J. Connolly;Mike Ezekowitz

  • Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Micheal E. Bertrand;Maarten L. Simoons;Keith A.A. Fox;Lars C. Wallentin

  • Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

    Salim Yusuf;Shamir R. Mehta;Susan Chrolavicius;Rizwan Afzal

  • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial

    Lars Wallentin;Salim Yusuf;Michael D Ezekowitz;Marco Alings

  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

    Eric Boersma;Robert A Harrington;David J Moliterno;Harvey White

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

    Yusuf S;Mehta;Chrolavicius S;Afzal R

  • Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

    Francesco Costa;Francesco Costa;Francesco Costa;David van Klaveren;David van Klaveren;Stefan James;Dik Heg

  • A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

    D Hasdai;S Behar;L Wallentin;N Danchin

  • Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes: A Collaborative Meta-analysis of Randomized Trials

    Shamir R. Mehta;Christopher P. Cannon;Keith A. A. Fox;Lars Wallentin

  • The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

    Paul A. Reilly;Thorsten Lehr;Sebastian Haertter;Stuart J. Connolly

Frequent Co-Authors

Agneta Siegbahn
Agneta Siegbahn Uppsala University
Stefan James
Stefan James Uppsala University
Christopher B. Granger
Christopher B. Granger Duke University
Renato D. Lopes
Renato D. Lopes Duke University
Claes Held
Claes Held Uppsala University
John H. Alexander
John H. Alexander Duke University
Robert F. Storey
Robert F. Storey University of Sheffield
Harvey D. White
Harvey D. White Auckland City Hospital
Robert A. Harrington
Robert A. Harrington Cornell University
Salim Yusuf
Salim Yusuf McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens up diverse opportunities beyond the traditional MD path. Many healthcare professionals enhance their expertise or shift their focus through specialized online degrees. For example, those interested in mental health may consider online msn pmhnp programs, which train nurses to provide psychiatric care—one of the fastest growing fields in healthcare.

If you’re passionate about leadership and organizational roles, an online healthcare administration degree offers affordable and flexible pathways to management positions in hospitals and healthcare organizations. Additionally, cost-conscious students may want to explore the cheapest master's in healthcare administration to further lower tuition expenses while gaining specialized skills.

For those aiming to reach the highest levels of advanced nursing, the cheapest dnp programs balance rigorous doctoral training with online accessibility. Each of these online health degrees can open new career doors, whether you plan to stay clinical, move into administration, or pursue research.

Best Scientists Citing Lars Wallentin

Trending Scientists

Recently Published Articles